Aurora Spine entered into a joint co-marketing agreement with Echolight Medical, manufacturer of the radiation-free EchoS portable densitometer for patient assessment of bone mineral density (BMD) and the quality of bone microarchitecture, independent of BMD.
Aurora has developed DEXA Technology-based Spinal Implants, and Echolight is engaged in the business of bone health assessment without the use of ionizing radiation. The two companies will promote each other’s products as part of the Aurora DEXA Platform.
This mutual effort allows Aurora to combine Echolight’s bone health assessment capabilities with its proprietary DEXA Technology-based patient matched spinal implants and allows Echolight to market and promote Echolight’s devices to determine which of Aurora’s DEXA Technology implants is most appropriate for each patient’s bone quality, be it normal, osteopenic or osteoporotic.
Trent Northcutt, CEO and President at Aurora Spine, said, “This joint effort will provide patients with a one-stop shop for patient matched implants based on quick and accurate real-time bone quality analysis with immediately available reports. We firmly believe that our partnership and shared passion will expand health care access to more people.”
Aurora Spine entered into a joint co-marketing agreement with Echolight Medical, manufacturer of the radiation-free EchoS portable densitometer for patient assessment of bone mineral density (BMD) and the quality of bone microarchitecture, independent of BMD.
Aurora has developed DEXA Technology-based Spinal Implants, and Echolight is engaged in...
Aurora Spine entered into a joint co-marketing agreement with Echolight Medical, manufacturer of the radiation-free EchoS portable densitometer for patient assessment of bone mineral density (BMD) and the quality of bone microarchitecture, independent of BMD.
Aurora has developed DEXA Technology-based Spinal Implants, and Echolight is engaged in the business of bone health assessment without the use of ionizing radiation. The two companies will promote each other’s products as part of the Aurora DEXA Platform.
This mutual effort allows Aurora to combine Echolight’s bone health assessment capabilities with its proprietary DEXA Technology-based patient matched spinal implants and allows Echolight to market and promote Echolight’s devices to determine which of Aurora’s DEXA Technology implants is most appropriate for each patient’s bone quality, be it normal, osteopenic or osteoporotic.
Trent Northcutt, CEO and President at Aurora Spine, said, “This joint effort will provide patients with a one-stop shop for patient matched implants based on quick and accurate real-time bone quality analysis with immediately available reports. We firmly believe that our partnership and shared passion will expand health care access to more people.”
Copy to clipboard 
